跳至主要内容
临床试验/NCT00490828
NCT00490828已完成4 期

Influence of Hydrocortisone on Humoral and Cellular Immunologic Markers in High Risk Patients After Cardiac Surgery

Ludwig-Maximilians - University of Munich1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2007年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
120
试验地点
1
主要终点
immunologic markers, health care related quality of life, PTSD

研究概览

简要总结

Hydrocortisone has been shown to improve the early outcome of high risk patients after cardiac surgery. A potential mechanism resulting in this effect may be its immunomodulatory action. In this prospective interventional study this hypothesis is to be proven.

详细描述

Methods: Prospective interventional randomized double blind placebo controlled study.

Intervention: Hydrocortisone in stress doses vs. placebo

Patients: 92 high risk patients after cardiac surgery

Measurements: Cytokines, Toll-like receptors, NF kappa B, outcome data, health care related quality of life, PTSD.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Participant, Care Provider)

入排标准

性别
All
接受健康志愿者

入选标准

  • Preoperative left ventricular ejection fraction below 39 % duration of the extracorporeal circulation more than 97 min

排除标准

  • Pregnancy
  • Severe liver insufficiency
  • Severe renal insufficiency
  • Insulin dependent diabetes mellitus
  • Steroid therapy
  • Psychiatric disease

研究组 & 干预措施

A

Placebo Comparator

干预措施: Hydrocortisone (Drug)

B

Active Comparator

Stress doses of hydrocortisone

干预措施: Hydrocortisone (Drug)

结局指标

主要结局

immunologic markers, health care related quality of life, PTSD

时间窗: one and a half year

次要结局

  • early clinical outcome parameters (LOS in the ICU)(one year)

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验

Influence of Hydrocortisone on Immunologic Markers... | 临床试验